You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 258 No. 13, October 2, 1987 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Compulsory Premarital Screening for the Human Immunodeficiency Virus

Technical and Public Health Considerations

Paul D. Cleary, PhD; Michael J. Barry, MD; Kenneth H. Mayer, MD; Allan M. Brandt, PhD; Larry Gostin, JD; Harvey V. Fineberg, MD, PhD

JAMA. 1987;258(13):1757-1762.


Abstract

The effectiveness of a mandatory premarital screening program was examined as a means of curtailing the spread of the human immunodeficiency virus (HIV) infection in the United States. The epidemiology of the HIV, the technical characteristics of tests for antibodies to HIV, and the logistic, economic, and legal implications of such a program were considered. In one year, universal premarital screening in the United States currently would detect fewer than one tenth of 1% of HIV-infected individuals at a cost of substantially more than $100 million. More than 100 infected individuals would be told that they were probably not infected, and there would likely be more than 350 false-positive results. Public education, counseling of individuals, and discretionary testing can be important tools in reducing the spread of HIV infection, but mandatory premarital screening in a population with a low prevalence of infection is a relatively ineffective and inefficient use of resources.

(JAMA 1987;258:1757-1762)



Footnotes

This paper is a summary of work conducted by a subgroup of the Study Group on Acquired Immunodeficiency Syndrome and Public Policy in the Division of Health Policy Research and Education at Harvard University, Boston.

Reprint requests to Office of the Dean, Harvard School of Public Health, 677 Huntington Ave, Boston, MA 02115 (Dr Fineberg).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Premarital screening programmes for haemoglobinopathies, HIV and hepatitis viruses: review and factors affecting their success
Alswaidi and O'Brien
J Med Screen 2009;16:22-28.
ABSTRACT | FULL TEXT  

The Cost-Effectiveness of HIV Testing: Accounting for Differential Participation Rates
Paltiel and Kaplan
Med Decis Making 1997;17:490-495.
ABSTRACT  

The Cost-effectiveness of Voluntary Counseling and Testing of Hospital Inpatients for HIV Infection
Lurie et al.
JAMA 1994;272:1832-1838.
ABSTRACT  

The Cost-effectiveness of HIV Testing of Physicians and Dentists in the United States
Phillips et al.
JAMA 1994;271:851-858.
ABSTRACT  

The HIV-Infected Health Care Professional: Public Policy, Discrimination, and Patient Safety
Gostin
J Law Med Ethics 1990;18:303-310.
 

Mandatory Premarital Testing for Human Immunodeficiency Virus: The Illinois Experience
Turnock and Kelly
JAMA 1989;261:3415-3418.
ABSTRACT  

AIDS: The Ethical Dilemma for burgeons
Peterson
J Law Med Ethics 1989;17:139-144.
 

Voluntary Screening for Human Immunodeficiency Virus (HIV) Infection: Weighing the Benefits and Harms
Bernard et al.
ANN INTERN MED 1989;110:727-733.
ABSTRACT  

Performance Characteristics of Serologic Tests for Human Immunodeficiency Virus Type 1 (HIV-1) Antibody among Minnesota Blood Donors: Public Health and Clinical Implications
MacDonald et al.
ANN INTERN MED 1989;110:617-621.
ABSTRACT  

Public Health Strategies for Confronting AIDS: Legislative and Regulatory Policy in the United States
Gostin
JAMA 1989;261:1621-1630.
ABSTRACT  

AIDS Testing and Informed Consent
Swartz
Journal of Health Politics, Policy and Law 1988;13:607-621.
ABSTRACT  

Border Hopping as a Consequence of Premarital HIV Screening: The Kenosha Diamond
Belongia et al.
JAMA 1988;260:1883-1884.
ABSTRACT  

Premarital Screening for HIV
Nadler
JAMA 1988;259:3127-3127.
ABSTRACT  

Premarital Screening for HIV
Buttery
JAMA 1988;259:3127-3128.
ABSTRACT  

Human Immunodeficiency Virus Test Evaluation, Performance, and Use: Proposals to Make Good Tests Better
Schwartz et al.
JAMA 1988;259:2574-2579.
ABSTRACT  

Routine Preoperative Screening for HIV: Does the Risk to the Surgeon Outweigh the Risk to the Patient?
Hagen et al.
JAMA 1988;259:1357-1359.
ABSTRACT  

Compulsory Premarital Screening for HIV
Allain and Daniels
JAMA 1988;259:1011-1012.
ABSTRACT  

Policy Review Essay: Insurers, Consumers, and Testing: The AIDS Experience
Hiam
J Law Med Ethics 1987;15:212-222.
 

PREMARITAL SCREENING FOR AIDS WOULD BE INEFFECTIVE
JWatch General 1987;1987:5-5.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.